Recent studies have shown that NEAT1 is closely associated with chemoresistance in a variety of cancers, and can regulate the sensitivity of cancers such as myeloma and glioblastoma to chemotherapeutic agents through multiple pathways and pleiotropic effects, thus affecting the efficacy of cancer chemotherapy [28–30]. Here, NEAT1 is linked to glioblastoma.